HOUSE_OVERSIGHT_024033.jpg
2.2 MB
Extraction Summary
2
People
4
Organizations
0
Locations
0
Events
1
Relationships
2
Quotes
Document Information
Type:
Financial performance report / investment summary
File Size:
2.2 MB
Summary
This document is a confidential financial report summarizing the investment performance of New Leaf Ventures and Sprout Funds by sector as of March 31, 2014. It details performance metrics (Gross Value, Multiple, and IRR) for Biopharmaceutical and Information Convergence investments across multiple funds dating back to 1993. The document carries a House Oversight Committee stamp, indicating it was part of a congressional investigation.
People (2)
| Name | Role | Context |
|---|---|---|
| Fund Managers | Investment Managers |
Mentioned in the context of having an established track record in the Sprout Funds.
|
| New Leaf team | Investment Team |
Group responsible for the biopharmaceutical investment performance.
|
Organizations (4)
| Name | Type | Context |
|---|---|---|
| New Leaf Ventures II, L.P. |
Investment fund established in 2008; listed in performance tables.
|
|
| New Leaf Ventures I, L.P. |
Investment fund established in 2005; listed in performance tables.
|
|
| Sprout Funds |
Group of funds (1993, 1995, 1998, 2000) listed in performance tables.
|
|
| House Oversight Committee |
Implied by the footer stamp 'HOUSE_OVERSIGHT_024033'.
|
Relationships (1)
The document compares New Leaf funds alongside Sprout Funds and mentions the Fund Managers had a track record in Sprout Funds.
Key Quotes (2)
"In aggregate, the New Leaf team has invested $945 million in 64 biopharmaceutical investments, and the historic realized biopharmaceutical results are 2.29x gross realized cash-on-cash return ("Multiple") and a 21.4% gross realized IRR."Source
HOUSE_OVERSIGHT_024033.jpg
Quote #1
"While New Leaf restarted new investment activity in information convergence opportunities in NLV-II, the Fund Managers already had an established track record in this sector from 9 investments in the Sprout Funds."Source
HOUSE_OVERSIGHT_024033.jpg
Quote #2
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document